Case Report: Cutaneous niche-restricted malignant phenotypes in PTCL-NOS revealed by single-cell sequencing - Summary - MDSpire

Case Report: Cutaneous niche-restricted malignant phenotypes in PTCL-NOS revealed by single-cell sequencing

  • By

  • Shucheng Zhang

  • Zhuqing Li

  • Yang Lin

  • Xiaoyue Sun

  • Meng Qiao

  • Xiaoqing Si

  • May 26, 2026

Share

Objective:

To investigate the tissue-specific molecular mechanisms driving cutaneous aggression in PTCL-NOS using single-cell RNA sequencing, highlighting the significance of these mechanisms in treatment outcomes.

Key Findings:
  • Skin-resident malignant T cells exhibited hyperproliferative phenotypes and activation of NF-κB and IL-17 signaling, suggesting a role in tumor aggressiveness.
  • Blood-derived lymphoma cells displayed immune evasion signatures and metabolic stress markers.
  • Distinct tissue-specific transcriptional programs were identified in skin and blood compartments.
Interpretation:

The study reveals how the cutaneous microenvironment influences aggressive malignant phenotypes in PTCL-NOS, potentially guiding future therapeutic strategies.

Limitations:
  • The study is based on a single case, limiting generalizability.
  • Further research is needed to validate findings across larger cohorts and explore therapeutic implications.
Conclusion:

This case study highlights the potential for compartment-specific therapy targeting the unique microenvironment of PTCL-NOS, emphasizing the need for tailored treatment approaches.

Original Source(s)

Case Report: Cutaneous niche-restricted malignant phenotypes in PTCL-NOS revealed by single-cell sequencing

  • by Shucheng Zhang, Zhuqing Li, Yang Lin, Xiaoyue Sun, Meng Qiao, Xiaoqing Si

  • May 26, 2026

Related Content

Beyond Nodule Detection: AI, Chest CT, and a Vision for Population Health

Lung cancer resulted in 1.8 million deaths globally in 2022 and remains the leading cause of cancer-related mortality worldwide. Low-dose CT screening has been shown to reduce lung cancer mortality, a...

Preclinical Study in Mice Addresses a Question: Should RAS Inhibitors Be Given Preemptively?

With recent data that RAS inhibition can improve survival in metastatic pancreatic cancer, the optimization of these agents has become a research priority. Minh Than, MD, PhD, a clinical and research ...

2026 NCCN Clinical Practice Guidelines in Oncology®: Key Updates Across Tumor Types

The National Comprehensive Cancer Network® (NCCN®) first introduced the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) in 1996, initially covering eight tumor types. Three decades la...